Iovance Biotherapeutics Inc (IOVA)

NASDAQ HEALTHCARE

$3.91 -0.51% RSI 54 Neutral Add Alert

Moving Averages

SMA 200

$2.91

Price above

Company Profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.72B

P/E Ratio

None

EPS

$-0.92

Beta

0.698